Figure 4. Assessment of efficacy, patient satisfaction, and adverse effects
A) Efficacy of treatment was determined at week 6, 12, 33, and 52 after treatment was initiated by IGA grading. B) Patient satisfaction was assessed at the final evaluation at week 52 by grading satisfaction on a 5-point Likert scale (very dissatisfied, dissatisfied, no opinion, satisfied and very satisfied). C) Treatment associated adverse effects were reported by the patients after each FLE treatment session through use of a questionnaire grading side-effects according to experienced as mild, tolerable, unpleasant, or intolerable.